Trinity Biotech (TRIB) Share-based Compensation Growth (1y) (2010 - 2024)
Trinity Biotech (TRIB) Share-based Compensation Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -30.44% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 59.09% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 113.88% |
| Sep 30, 2024 | -66.12% |
| Jun 30, 2024 | -88.31% |
| Mar 31, 2024 | -40.47% |
| Dec 31, 2023 | -176.56% |
| Sep 30, 2023 | -99.38% |
| Jun 30, 2023 | 699.18% |
| Dec 31, 2022 | 755.84% |
| Jun 30, 2022 | -60.90% |
| Dec 31, 2016 | -9.74% |
| Dec 31, 2015 | -26.12% |
| Dec 31, 2012 | 90.71% |
| Dec 31, 2011 | 11.49% |
| Dec 31, 2010 | 67.06% |